Literature DB >> 35290650

Evaluation of the anticandidal activity of clotrimazole using Lactobacillus caseie ghosts as biological drug carrier.

Touba Eslaminejad1,2, Mohammad Hassan Moshafi2, Matineh Hasanpore1, Seyed Amin Ayatollahi3, Mehdi Ansari4,5.   

Abstract

BACKGROUND: Candida albicans cause oral and vaginal mucosa infections as well as bloodstream and deep-tissue infections. Commonly, clotrimazole as a broad-spectrum antimitotic drug applied for treatment of Candida albicans infections. Bacterial ghosts are dead cells that have the broad potential to target the various body tissues and cells as drug vector.
OBJECTIVES: We hope to conquest this resistance by using clotrimazole loaded on bacterial ghosts.
METHODS: Lactobacillus ghosts were produced by using tween 80 and lactic acid according to the protocol and the amount of the DNA and protein in supernatant was measured by Nano-drop spectrophotometry. Ghost's morphological characteristics were detected by using light microscopy, SEM and AFM. Antifungal activities of the synthesized ghosts were measured by plate methods. Three independent vertical Franz cells were used to evaluate drug release profile. BG-clotrimazole was added into cream base and was examined for dispensability as well as uniformity of the formulation on the skin.
RESULTS: Results of the Nano-drop analysis showed that protein and DNA was seen in supernatant of treatment compared to control groups. AFM results showed well-dispersed and rod-shaped L. casei ghost cells. Lysis pores formation in the L. casei ghosts was indicated by SEM micrographs. BGs represent an excellent drug delivery system because of the high loading capability. Nearly, 50% of clotrimazole was released from BGs during 90 min. Highest anticandidal activity occurred using 100 mg/l clotrimazole-BG, while toxic effects were also seen with 10 mg/l clotrimazole. IC50 clotrimazole-BG was found at 0.001 mg/l. Chemical stability results showed that about 90% of clotrimazole remained in the formulation.
CONCLUSION: It could be concluded that the bacterial ghosts are very talented to high loading capability, keeping and releasing drug during six months, therefore these could act as an excellent drug delivery system.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Bacterial ghost; Clotrimazole; Formulation; Lactobacillus casei; Vulvovaginal candidiasis

Mesh:

Substances:

Year:  2022        PMID: 35290650      PMCID: PMC9114249          DOI: 10.1007/s40199-022-00432-0

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   4.088


  20 in total

1.  A review on preparation and chemical analysis of postbiotics from lactic acid bacteria.

Authors:  Mehran Moradi; Rahim Molaei; Jonas T Guimarães
Journal:  Enzyme Microb Technol       Date:  2020-12-03       Impact factor: 3.493

Review 2.  Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.

Authors:  Gamaleldin I Harisa; Abdelrahman Y Sherif; Abdullah M E Youssof; Fars K Alanazi; Mounir M Salem-Bekhit
Journal:  AAPS PharmSciTech       Date:  2020-06-08       Impact factor: 3.246

Review 3.  Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy.

Authors:  Pratigyan Dash; Anna Maria Piras; Mamoni Dash
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

4.  Immobilization of vaginal Lactobacillus in polymeric nanofibers for its incorporation in vaginal probiotic products.

Authors:  Jessica Alejandra Silva; Priscilla Romina De Gregorio; Guadalupe Rivero; Gustavo A Abraham; María Elena Fátima Nader-Macías
Journal:  Eur J Pharm Sci       Date:  2020-09-23       Impact factor: 4.384

Review 5.  Phages and their potential to modulate the microbiome and immunity.

Authors:  Sara Federici; Samuel P Nobs; Eran Elinav
Journal:  Cell Mol Immunol       Date:  2020-09-08       Impact factor: 11.530

6.  Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.

Authors:  Eline F M Oerlemans; Gert Bellen; Ingmar Claes; Tim Henkens; Camille Nina Allonsius; Stijn Wittouck; Marianne F L van den Broek; Sander Wuyts; Filip Kiekens; Gilbert G G Donders; Sarah Lebeer
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.379

Review 7.  An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains.

Authors:  Sara B Salazar; Rita S Simões; Nuno A Pedro; Maria Joana Pinheiro; Maria Fernanda N N Carvalho; Nuno P Mira
Journal:  J Fungi (Basel)       Date:  2020-02-10

8.  Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis.

Authors:  Shirin Farahyar; Samira Izadi; Elham Razmjou; Mehraban Falahati; Maryam Roudbary; Mahtab Ashrafi-Khozani; Saham Ansari; Azam Fattahi; Zahra Ghahri-Mobaser; Maryam Rahimi
Journal:  Heliyon       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.